Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1905 2
1906 3
1907 1
1908 2
1909 1
1910 3
1911 2
1912 1
1913 1
1914 2
1915 3
1916 1
1917 1
1919 2
1920 1
1923 1
1924 2
1925 1
1926 4
1927 4
1928 2
1929 3
1930 1
1931 1
1936 1
1937 1
1941 1
1945 5
1946 13
1947 10
1948 11
1949 5
1950 2
1951 6
1952 3
1953 3
1954 6
1955 2
1956 7
1957 5
1958 5
1959 7
1960 3
1961 5
1962 8
1963 4
1964 10
1965 6
1966 12
1967 10
1968 10
1969 14
1970 10
1971 24
1972 21
1973 23
1974 24
1975 28
1976 27
1977 25
1978 22
1979 29
1980 34
1981 26
1982 34
1983 34
1984 16
1985 28
1986 21
1987 25
1988 24
1989 19
1990 34
1991 23
1992 22
1993 28
1994 35
1995 39
1996 30
1997 29
1998 40
1999 41
2000 44
2001 38
2002 38
2003 33
2004 52
2005 78
2006 59
2007 64
2008 56
2009 42
2010 60
2011 53
2012 62
2013 71
2014 82
2015 96
2016 93
2017 89
2018 104
2019 91
2020 124
2021 112
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

2,426 results
Results by year
Filters applied: . Clear all
Page 1
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination.
Marshall M, Ferguson ID, Lewis P, Jaggi P, Gagliardo C, Collins JS, Shaughnessy R, Caron R, Fuss C, Corbin KJE, Emuren L, Faherty E, Hall EK, Di Pentima C, Oster ME, Paintsil E, Siddiqui S, Timchak DM, Guzman-Cottrill JA. Marshall M, et al. Among authors: lewis p. Pediatrics. 2021 Sep;148(3):e2021052478. doi: 10.1542/peds.2021-052478. Epub 2021 Jun 4. Pediatrics. 2021. PMID: 34088762
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI; HEP-COVID Investigators. Spyropoulos AC, et al. Among authors: lewis pa. JAMA Intern Med. 2021 Dec 1;181(12):1612-1620. doi: 10.1001/jamainternmed.2021.6203. JAMA Intern Med. 2021. PMID: 34617959 Clinical Trial.
Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets.
Kia DA, Zhang D, Guelfi S, Manzoni C, Hubbard L, Reynolds RH, Botía J, Ryten M, Ferrari R, Lewis PA, Williams N, Trabzuni D, Hardy J, Wood NW; United Kingdom Brain Expression Consortium (UKBEC) and the International Parkinson’s Disease Genomics Consortium (IPDGC). Kia DA, et al. Among authors: lewis pa. JAMA Neurol. 2021 Apr 1;78(4):464-472. doi: 10.1001/jamaneurol.2020.5257. JAMA Neurol. 2021. PMID: 33523105 Free PMC article.
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.
Krug B, De Jay N, Harutyunyan AS, Deshmukh S, Marchione DM, Guilhamon P, Bertrand KC, Mikael LG, McConechy MK, Chen CCL, Khazaei S, Koncar RF, Agnihotri S, Faury D, Ellezam B, Weil AG, Ursini-Siegel J, De Carvalho DD, Dirks PB, Lewis PW, Salomoni P, Lupien M, Arrowsmith C, Lasko PF, Garcia BA, Kleinman CL, Jabado N, Mack SC. Krug B, et al. Among authors: lewis pw. Cancer Cell. 2019 May 13;35(5):782-797.e8. doi: 10.1016/j.ccell.2019.04.004. Cancer Cell. 2019. PMID: 31085178 Free PMC article.
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, Murphy D, Venneti S, Hameed M, Pawel BR, Wunder JS, Dickson BC, Lundgren SM, Jani KS, De Jay N, Papillon-Cavanagh S, Andrulis IL, Sawyer SL, Grynspan D, Turcotte RE, Nadaf J, Fahiminiyah S, Muir TW, Majewski J, Thompson CB, Chi P, Garcia BA, Allis CD, Jabado N, Lewis PW. Lu C, et al. Among authors: lewis pw. Science. 2016 May 13;352(6287):844-9. doi: 10.1126/science.aac7272. Science. 2016. PMID: 27174990 Free PMC article.
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.
Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Sharifova G, Cohen M, Lund JM, Mignatti A, Gianos E, Tafur A, Lewis PA, Cohoon K, Kittelson JM, Lesser ML, Sison CP, Rahman H, Ochani K, Hiatt WR, Dale RA, Anderson VE, Bonaca M, Halperin JL, Weitz JI, Spyropoulos AC. Goldin M, et al. Among authors: lewis pa. Thromb Haemost. 2021 Dec;121(12):1684-1695. doi: 10.1055/a-1475-2351. Epub 2021 Apr 6. Thromb Haemost. 2021. PMID: 33823560
Turning mesoderm into kidney.
Davidson AJ, Lewis P, Przepiorski A, Sander V. Davidson AJ, et al. Among authors: lewis p. Semin Cell Dev Biol. 2019 Jul;91:86-93. doi: 10.1016/j.semcdb.2018.08.016. Epub 2018 Sep 1. Semin Cell Dev Biol. 2019. PMID: 30172050 Review.
2,426 results